Published Works | Westlaw Journal | 03 May 2016

Considerations for Device Firms in the Wake of a String of Successful First Amendment Challenges to FDA's Regulation of Off-Label Speech

Over the past few years, we have witnessed an erosion of the Food and Drug Administration's restriction of off-label speech through several court cases that have challenged the constitutionality of these restrictions on manufacturers' speech.

Read More: Considerations for Device Firms in the Wake of a String of Successful First Amendment Challenges to FDA's Regulation of Off-Label Speech

Download PDF Back To Listing